QuidelOrtho Corp.

Company Overview

QuidelOrtho Corporation develops and markets immunoassay and molecular testing, clinical chemistry, and transfusion medicine products. Its production plants in the U.S. and the U.K., sales offices, administrative buildings, and warehouses spread out across the globe. Through a direct sales force and a network of distributors, they sell their products directly to end users for both individual, non-professional, over-the-counter ("OTC") use and professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, top universities, retail clinics, pharmacies, wellness screening centers, other point-of-care ("POC") settings, blood banks, and donor centers.

The company operates in 4 business units, including labs, molecular diagnostics, point of care, and transfusion medicine. Products related to detecting influenza A and B types are offered through the molecular diagnostics business unit and the point of care segment.

Financial Highlights (FY 2024)

Company's Business Segments

• Labs : Virology, Specialty Products, Clinical Chemistry, Immunodiagnostics, Vitros Platform, Vitros XT Platform, Vitros Results Management, Vitros Automation Solutions
• Immunohematology : ORTHO VISION Platform, Ortho Workstation, Ortho Optix, ID-Micro Typing System (ID-MTS) Gel Cards, BIOVUE Cassettes, Ortho Sera Reagents, Donor Testing Serology
• Point of Care : Sofia and Sofia 2, QuickVue, InflammaDry and AdenoPlus, Triage and Triage MeterPro
• Molecular Diagnostics : Lyra, Solana, Savanna
• Transfusion Medicine : Transfusion Medicine business unit includes two product categories Immunohematology, Donor Screening.